首页> 外文OA文献 >Real‐world safety and efficacy data of ipilimumab in Japanese radically unresectable malignant melanoma patients: A postmarketing surveillance

【2h】

Real‐world safety and efficacy data of ipilimumab in Japanese radically unresectable malignant melanoma patients: A postmarketing surveillance

机译：IPILIMIMAB在日语无可切除恶性黑色素瘤患者中的真实世界的安全性和有效性数据：每艘邮政监测

代理获取

本网站仅为用户提供外文OA文献查询和代理获取服务，本网站没有原文。下单后我们将采用程序或人工为您竭诚获取高质量的原文，但由于OA文献来源多样且变更频繁，仍可能出现获取不到、文献不完整或与标题不符等情况，如果获取不到我们将提供退款服务。请知悉。

页面导航

著录项
引文网络
相似文献
相关主题

著录项

作者
Naoya Yamazaki; Yoshio Kiyohara; Hisashi Uhara; Tetsuya Tsuchida; Keiko Maruyama; Naoki Shakunaga; Eijun Itakura; Akira Komoto;
展开▼
作者单位

展开▼
年度 2020
总页数
原文格式 PDF
正文语种
中图分类

相似文献

外文文献
中文文献
专利

1. Real-world safety and efficacy data of ipilimumab in Japanese radically unresectable malignant melanoma patients: A postmarketing surveillance [J] . The Journal of dermatology . 2020,第8期

机译：日本无可切除恶性黑素瘤患者IpiLimumab的真实世界安全性和有效数据：一期邮政监测
2. Safety and efficacy of nivolumab in Japanese patients with malignant melanoma: An interim analysis of a postmarketing surveillance [J] . Kiyohara Yoshio, Uhara Hisashi, Ito Yoshihiko, The Journal of dermatology . 2018,第4期

机译：Nivolumab在日本恶性黑色素瘤患者中的安全性和有效性：临时分析对邮政监测的临时分析
3. 7003 ORAL Ipilimumab (MDX-010) in patients with unresectable stage III or IV malignant melanoma: efficacy and safety data from a phase I trial [J] . J.Weber, E.Hersh, M.Yellin, European Journal of Cancer Supplements . 2007,第4期

机译：不可切除的III或IV期恶性黑色素瘤患者的7003口服Ipilimumab（MDX-010）：I期试验的有效性和安全性数据
4. Hyperthermia Combined With Radiotherapy on 13 Cases of Late Stage Malignant Melanoma Patients [C] . The 3rd Asian congress on hyperthermic oncology and the 9th Chineses symposium on hyperthermic oncology . 2002

机译：热疗联合放疗治疗晚期恶性黑色素瘤13例
5. Self-controlled methods for postmarketing drug safety surveillance in large-scale longitudinal data. [D] . Simpson, Shawn E. 2011

机译：大规模纵向数据中用于售后药品安全监视的自控方法。
6. Randomized Open-Label Phase II Study Evaluating the Efficacy and Safety of Talimogene Laherparepvec in Combination With Ipilimumab Versus Ipilimumab Alone in Patients With Advanced Unresectable Melanoma [O] . Jason Chesney, Igor Puzanov, Frances Collichio, -1

机译：评估Talimogene Laherparepvec联合Ipilimumab与单独Ipilimumab联合治疗晚期无法切除的黑色素瘤的疗效和安全性的随机开放标签II期临床研究
7. Correction to: Inhibitor development, safety, and efficacy of Advate® in previously untreated patients with hemophilia A in a postmarketing surveillance in Japan [O] . Masashi Taki, Katsuyuki Fukutake, Tadashi Matsushita, 2018

机译：校正：促进®在血友病A中的血友病患者中抑制剂的抑制剂开发，安全性和疗效，在日本的一期血友病患者中

Real‐world safety and efficacy data of ipilimumab in Japanese radically unresectable malignant melanoma patients: A postmarketing surveillance

著录项

引文网络

相似文献

相关主题

期刊订阅